Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant vs Hybrid Therapy for H. pylori
NCT03572777Completed
- Start
- Apr 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of amoxicillin, metronidazole, clarithromycin and esomeprazole in Helicobacter pylori infection (2 arms). Primary endpoint: Helicobacter pylori status. Started Apr 2018; status: completed.
02
Drugs
amoxicillinmetronidazoleclarithromycinesomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03572777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03572777.